Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Cancers
|
December 24, 2021
Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma
Carolin Sauter-Meyerhoff, Regina Bohnert, Pascale Mazzola, et al.
Plos One
|
August 12, 2022
Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancer
Olga Katzendorn, Christoph A J von Klot, Samy Mahjoub, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 23, 2020
Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD
Shufei Zeng, Uwe Querfeld, Martina Feger, et al.
Clinical and Translational Medicine
|
June 9, 2022
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
Anna Reustle, Lena-Sophie Menig, Patrick Leuthold, et al.
Clinical Genitourinary Cancer
|
November 28, 2024
Safety and Efficacy of <sup>177</sup>Lu-PSMA Therapy Following <sup>223</sup>Radium Treatment: A Retrospective Multinational Real-World Analysis
Giulia Giannini, Mona Kafka, Hannes Neuwirt, et al.
Scientific Reports
|
July 21, 2016
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
Stefan Winter, Pascale Fisel, Florian Büttner, et al.
Archives of Gynecology and Obstetrics
|
November 7, 2022
Uterine allograft removal by total laparoscopic hysterectomy after successful cesarean delivery in a living-donor uterus recipient with uterovaginal agenesis (MRKHS)
Sara Yvonne Brucker, Bernhard Krämer, Harald Abele, et al.
Genome Medicine
|
April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
Genome Medicine
|
September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
Florian A Büttner, Stefan Winter, Viktoria Stühler, et al.
The New England Journal of Medicine
|
February 18, 2026
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
Christof Vulsteke, Nabil Adra, Pongwut Danchaivijitr, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Cancers
|
December 24, 2021
Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma
Carolin Sauter-Meyerhoff, Regina Bohnert, Pascale Mazzola, et al.
Plos One
|
August 12, 2022
Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancer
Olga Katzendorn, Christoph A J von Klot, Samy Mahjoub, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 23, 2020
Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD
Shufei Zeng, Uwe Querfeld, Martina Feger, et al.
Clinical and Translational Medicine
|
June 9, 2022
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
Anna Reustle, Lena-Sophie Menig, Patrick Leuthold, et al.
Clinical Genitourinary Cancer
|
November 28, 2024
Safety and Efficacy of <sup>177</sup>Lu-PSMA Therapy Following <sup>223</sup>Radium Treatment: A Retrospective Multinational Real-World Analysis
Giulia Giannini, Mona Kafka, Hannes Neuwirt, et al.
Scientific Reports
|
July 21, 2016
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
Stefan Winter, Pascale Fisel, Florian Büttner, et al.
Archives of Gynecology and Obstetrics
|
November 7, 2022
Uterine allograft removal by total laparoscopic hysterectomy after successful cesarean delivery in a living-donor uterus recipient with uterovaginal agenesis (MRKHS)
Sara Yvonne Brucker, Bernhard Krämer, Harald Abele, et al.
Genome Medicine
|
April 2, 2020
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, et al.
Genome Medicine
|
September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
Florian A Büttner, Stefan Winter, Viktoria Stühler, et al.
The New England Journal of Medicine
|
February 18, 2026
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
Christof Vulsteke, Nabil Adra, Pongwut Danchaivijitr, et al.
Page
of 13